Work

Osteocytic signalling pathways as therapeutic targets for bone fragility

Year: 2016

Type: review

Source: Nature Reviews Endocrinology

DOI: 10.1038/nrendo.2016.71

Authors: Lilian I. Plotkin, Teresita Bellido

Institutions: Indiana University Indianapolis, Indiana University School of Medicine, Richard L. Roudebush VA Medical Center

Language: English

Topic: Bone Metabolism and Diseases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Research Resources

Awards: Glucocorticoid-induced Atrophy in Bone and Muscle, SkyScan 1172 High-resolution desk-top micro-CT system, G1554667050, G1729783615, G2142664082, Osteocyte control of bone formation via Sost, G558130469, Osteocyte Apoptosis and Regulation of Bone Resorption with Aging, G8992108187, Contribution of osteocytes to the musculoskeletal effects of Multiple Myeloma

OpenAlex ID: W2402913713

FWCI: 1.481

Cites: 169

Cited by: 205

Related to: 10